Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy.
Love C, Desai NB, Abraham T, Banks KP, Bodei L, Boike T, Brown RKJ, Bushnell DL, DeBlanche LE, Dominello MM, Francis T, Grady EC, Hobbs RF, Hope TA, Kempf JS, Pryma DA, Rule W, Savir-Baruch B, Sethi I, Subramaniam RM, Xiao Y, Schechter NR. Love C, et al. Among authors: rule w. Am J Clin Oncol. 2022 Jun 1;45(6):233-242. doi: 10.1097/COC.0000000000000903. Epub 2022 May 4. Am J Clin Oncol. 2022. PMID: 35507413
ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy.
Love C, Desai NB, Abraham T, Banks KP, Bodei L, Boike T, Brown RKJ, Bushnell DL, DeBlanche LE, Dominello MM, Francis T, Grady EC, Hobbs RF, Hope TA, Kempf JS, Pryma DA, Rule W, Savir-Baruch B, Sethi I, Subramaniam RM, Xiao Y, Schechter NR. Love C, et al. Among authors: rule w. Clin Nucl Med. 2022 Jun 1;47(6):503-511. doi: 10.1097/RLU.0000000000004182. Clin Nucl Med. 2022. PMID: 35507433
Clinical evaluation of fitness to drive in patients with brain metastases.
Valencia-Sanchez C, Gorelkin VC, Mrugala MM, Sharma A, Vora SA, Ashman JB, Daniels TB, Halyard MY, Rule WG, Zhang N, Butterfield RJ, Schild SE, Porter AB. Valencia-Sanchez C, et al. Neurooncol Pract. 2019 Dec;6(6):484-489. doi: 10.1093/nop/npz027. Epub 2019 Jul 3. Neurooncol Pract. 2019. PMID: 31832219 Free PMC article.
Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A Mayo Clinic Experience.
Bhangoo RS, DeWees TA, Yu NY, Ding JX, Liu C, Golafshar MA, Rule WG, Vora SA, Ross HJ, Ahn DH, Beamer SE, Jaroszewski DE, Hallemeier CL, Liu W, Ashman JB, Sio TT. Bhangoo RS, et al. Among authors: rule wg. Adv Radiat Oncol. 2020 May 19;5(5):871-879. doi: 10.1016/j.adro.2020.04.026. eCollection 2020 Sep-Oct. Adv Radiat Oncol. 2020. PMID: 33083649 Free PMC article.
Long-Term Results of a Phase 1 Dose-Escalation Trial and Subsequent Institutional Experience of Single-Fraction Stereotactic Ablative Radiation Therapy for Liver Metastases.
Folkert MR, Meyer JJ, Aguilera TA, Yokoo T, Sanford NN, Rule WG, Mansour J, Yopp A, Polanco P, Hannan R, Nedzi LA, Timmerman RD. Folkert MR, et al. Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1387-1395. doi: 10.1016/j.ijrobp.2020.12.012. Epub 2020 Dec 16. Int J Radiat Oncol Biol Phys. 2021. PMID: 33340601 Clinical Trial.
Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience.
Bhangoo RS, Mullikin TC, Ashman JB, Cheng TW, Golafshar MA, DeWees TA, Johnson JE, Shiraishi S, Liu W, Hu Y, Merrell KW, Haddock MG, Krishnan S, Rule WG, Sio TT, Hallemeier CL. Bhangoo RS, et al. Among authors: rule wg. Adv Radiat Oncol. 2021 Mar 2;6(4):100675. doi: 10.1016/j.adro.2021.100675. eCollection 2021 Jul-Aug. Adv Radiat Oncol. 2021. PMID: 34409199 Free PMC article.
70 results